Skip to content

Reviewing of the bowel preparation for Colon Capsule Endoscopy (Further Work)

Reviewing of the bowel preparation for Colon Capsule Endoscopy (Further Work) - C1 Prep Add

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004649
Enrollment
25
Registered
2010-12-01
Start date
2010-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects who undergo Colon Capsule Endoscopy

Interventions

Conduct a modified version of the Japan original 1 day bowel preparation method (Moisture load (Laxative): 3.8L, administration of laxative only on the test day, no breakfast on the test day only). Mo

Sponsors

National Cancer Center Hospital
Lead Sponsor
Jikei University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects are between 40 - 79 years of age and have planned to undergo Colonoscopy.

Exclusion criteria

Exclusion criteria: 1) Subjects who have a swallowing disorder 2) Subjects who have a history of allergic reaction to the following medicines (1 - 6) used in this study. These medicines are used normally in the clinical situations in Japan. 1. Polyethylene glycol 2. Magnesium citrate solution 3. Mosapride citrate 4. Dimethicone, Pronase, Sodium bicarbonate 5. Bisacodyl 6. Glycelin 3) Subjects who are pregnant 4) Subjects who have a cardiac pacemaker implanted or other medical electronic devices applied in the body 5) Subjects who have a suspected symptom or who have a history of intestinal obstruction or intestinal stenosis 6) Subjects who have a history of radiotherapy 7) Subjects who have Crohn's disease or ulcerative colitis 8) Other cases where doctors consider it inappropriate

Design outcomes

Primary

MeasureTime frame
Anus excretion rate

Secondary

MeasureTime frame
Colon cleansing level

Countries

Japan

Contacts

Public ContactYasuo Kakugawa MD

National Cancer Center, Research Center for Cancer Prevention and Screening Screening Technology and Development Division

03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026